Article
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
20 Nov 2018
Abstract excerpt
PURPOSE: An ASCO provisional clinical opinion (PCO) offers timely clinical direction to ASCO's membership and other health care providers. This PCO addresses identification and management of patients and family members with possible predisposition to pancreatic adenocarcinoma. METHODS: ASCO convened an Expert Panel and conducted a systematic review of the literature published from January 1998 to June 2018....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
